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Abstract
Background
The human retinal pigment epithelium (RPE) plays an important role in the pathogenesis of
age related macular degeneration (AMD). AMD is the leading cause of blindness worldwide.
There is currently no effective treatment available. Preclinical studies in AMDmouse mod-
els are essential to develop new therapeutics. This requires further in-depth knowledge of
the similarities and differences between mouse and human RPE.
Methods
We performed a microarray study to identify and functionally annotate RPE specific gene
expression in mouse and human RPE. We used a meticulous method to determine C57BL/
6J mouse RPE signature genes, correcting for possible RNA contamination from its adja-
cent layers: the choroid and the photoreceptors. We compared the signature genes, gene
expression profiles and functional annotations of the mouse and human RPE.
Results
We defined sets of mouse (64), human (171) and mouse–human interspecies (22) RPE sig-
nature genes. Not unexpectedly, our gene expression analysis and comparative functional
annotation suggested that, in general, the mouse and human RPE are very similar. For
example, we found similarities for general features, like “organ development” and “disorders
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related to neurological tissue”. However, detailed analysis of the molecular pathways and
networks associated with RPE functions, suggested also multiple species-specific differ-
ences, some of which may be relevant for the development of AMD. For example, CFHR1,
most likely the main complement regulator in AMD pathogenesis was highly expressed in
human RPE, but almost absent in mouse RPE. Furthermore, functions assigned to mouse
and human RPE expression profiles indicate (patho-) biological differences related to AMD,
such as oxidative stress, Bruch’s membrane, immune-regulation and outer blood retina
barrier.
Conclusion
These differences may be important for the development of new therapeutic strategies and
translational studies in age-related macular degeneration.
Introduction
Age related macular degeneration (AMD) is the leading cause of blindness worldwide. The dis-
ease affects 4% of the population over age 60. With the increase of the aging population, AMD
is becoming an even more important public health issue. The etiology of AMD remains largely
unknown. The first clinical manifestations of the disease include the appearance of sub-retinal
drusen and pigmentary or degenerative changes of the RPE. Ultimately, the disease affects the
RPE, Bruch’s membrane (BM), photoreceptors (PR) and choriocapillaries (CH). We focused
this study on the RPE.
The RPE is a monolayer of pigmented neuro-epithelial cells, which forms part of the outer
blood-retina barrier. It closely interacts with the PR to maintain visual function. The apical
membrane of the RPE faces the photoreceptor outer segments and its basolateral membrane
faces the BM. The BM separates the RPE from CH, which nourishes the RPE and outer layers
of the retina [1]. In healthy eyes, BM functions as a structural support that is permeable to fluid
and small molecules. Additionally it acts as a physical barrier, containing anti-angiogenic mole-
cules, which protect the retina against neovascularization [2,3].
A healthy RPE is essential for visual function. It supplies the PR with nutrients, absorbs the
excess light energy focused by the lens on the retina, recycles retinal from the PR, regulates the
ion balance in the sub retinal space and maintains the function and survival of the PR by
phagocytosis of the shed photoreceptor outer segments [1]. Failure of any of these functions
can lead to degeneration of the retina, loss of visual function and, eventually, blindness in reti-
nal diseases such as AMD or retinitis pigmentosa.
In AMD, RPE dysfunction or degeneration leads to a dystrophy of the PR and thereby
vision loss [4]. The early stage of AMD is characterized by the presence of drusen and vision
loss is relatively mild. Later stages of the disease involve two forms: the dry form (geographic
atrophy) and the wet form (choroidal neovascularization). Both forms affect about half of the
late stage AMD patients. AMD has a multifactorial etiology [5], and is caused by a variety of
environmental and genetic risk factors [4]. There is evidence that positive life style changes
(quit smoking; healthy food) and dietary supplements (Zn2+) may postpone the onset or pro-
gression of the disease [6]. Patient-unfriendly, repeated intra-ocular injections with anti-VEGF
may temporarily halt the progression of the wet form of AMD. However, it does not prevent
the atrophy of RPE and PR [7,8]. Once vision is lost, a possible (future) cure for AMDmay be
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cell replacement therapy. Pre-clinical experiments indicate that transplantation of stem cell
derived RPE cells can successfully be used to rescue PR and vision [9–11]. However, these pre-
clinical studies are predominantly performed in mice. To translate results and start clinical
studies in man further knowledge of the similarities and differences between mouse and
human RPE is essential.
In this study we compared the gene expression profiles and functional annotation of mouse
and human RPE on a single microarray platform to further improve translational studies.
Results
First, we determined the gene expression profiles of the mouse RPE, CH and PR (raw data avail-
able in the Gene Expression Omnibus database with the accession number GSE66916). We con-
firmed our microarray methodology by checking the expression of (well established) RPE genes
using semi-quantitative RT-PCR (sqRT-PCR) (Fig 1 and S1 Fig). Subsequently, we determined
mouse and human RPE signature genes, we defined the functionalities of the gene expression
profiles of mouse and man, and we analyzed the most extreme differences in RPE gene expres-
sion between the two species. Also these results were partly confirmed using sqRT-PCR (S2 Fig).
Mouse, human and inter-species RPE signature genes
In our lab, we previously designed a new strategy to select RPE signature genes (Fig 2). RPE
specificity was determined by comparison of the gene expression levels between the RPE and
Fig 1. Confirmation of microarray results by sqRT-PCR. Beta-actin (Bact), a housekeeping gene, was used to normalize gene expression in mouse CH,
RPE and PR. The light blue bars indicate expression levels in CH, the blue bars expression levels in the RPE and the dark blue bars indicate expression
levels in PR. Similar to the microarray data the expression level is highest in the RPE and lowest in the PR. The sqRT-PCR results confirm our findings;
however Tshr and Slc16a8 show expression lower in RPE compared to choroid. Overall, the sqRT-PCR confirmation rate in this, and in all our previous
studies (combined), using exactly the samemethodology and platform to investigate neuroepithelia from human donor eyes and brains was 87% [12–14].
doi:10.1371/journal.pone.0141597.g001
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its adjacent layers: the CH and PR [12]. In the current study, we applied this strategy to the
mouse retina in order to select mouse RPE signature genes.
We selected the genes that have a significant higher expression level in the mouse RPE com-
pared to their expression in the CH and the PR, with a fold change (FC) higher than 2.5 and a
B-H adjusted p-value<0.01. This resulted in a list of 64 genes that are specifically expressed in
the RPE relative to both its adjacent layers; the CH and PR. We annotated this set the “Mouse
RPE signature genes” dataset (see Table 1).
Using the same cut-off criteria; we determined a set of genes that is specific for the mouse
CH compared to the RPE and a set of genes mouse PR specific when compared to the RPE (S1
Table).
We next defined a new “Human RPE signature genes” dataset. We carefully selected two
previously published human RPE specific gene expression datasets for a comprehensive com-
parison between mouse and human RPE (Fig 3) [12,15]. The first study was conducted in our
lab using a similar methodology for determining RPE specific gene expression resulting in
identification of 114 RPE specifically expressed genes [12]. The second microarray study
included multiple RPE types but the investigators did not correct for possible contamination of
adjacent tissues [15]. For the latter dataset, we removed possible CH and PR RNA contamina-
tion (see Methods), and generated a list of 86 human RPE specifically expressed genes. We sub-
sequently merged the two human RPE specific gene expression datasets, resulting in 171
human RPE signature genes (S2 Table).
Fig 2. Strategy to select RPE signature genes. In the first step of this strategy we laser dissect the RPE (and its adjacent layers, the CH and PR) for
specific tissue collection. In the second step we statistically correct for possible contamination by adjacent layers.
doi:10.1371/journal.pone.0141597.g002
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Table 1. Our “Mouse RPE signature genes” dataset: 64 mouse RPE genes with an average expression of at least 2.5 fold higher in the mouse RPE
than in both the PR and the CH with an adjusted p-value smaller than 0.01.
CH<RPE>PR genes RPE compared to CH RPE compared to PR
GeneName SystematicName adj.P.Val FC RPE-CH adj P value FC RPE-PR
Rgr ENSMUST00000022338 5,93E-03 4,9 5,90E-06 306,1
LOC100045988 XM_001475309 6,03E-03 4,6 3,81E-03 3,5
Pon1 NM_011134 1,01E-03 4,2 2,10E-07 95,8
Rdh10 NM_133832 1,46E-03 4,1 9,38E-08 75,1
Arl6ip1 NM_019419 4,41E-03 3,2 2,73E-06 24,6
Rlbp1 NM_020599 5,78E-03 3,2 4,29E-07 42,4
Tbx5 NM_011537 2,65E-03 3,2 3,61E-04 3,5
Bmp4 NM_007554 3,03E-03 3,2 2,31E-05 47,9
F3 NM_010171 1,42E-03 3,1 4,09E-07 102,2
5730469M10Rik NM_027464 2,28E-03 3,1 1,03E-06 14,0
Rrh NM_009102 2,40E-03 3,1 8,94E-08 47,2
Man1a NM_008548 2,07E-04 3,0 6,11E-08 10,3
Sema3c NM_013657 5,52E-04 2,9 9,66E-08 504,3
Vldlr NM_013703 1,35E-03 2,9 1,79E-05 4,6
Atp1b1 NM_009721 2,54E-03 2,9 1,29E-07 34,1
Ctsd NM_009983 6,72E-03 2,9 6,81E-05 5,7
Cspg5 NM_001166273 5,34E-03 2,9 1,94E-06 15,1
Cldn2 NM_016675 6,79E-04 2,9 6,75E-07 7,8
Sulf1 NM_172294 4,05E-04 2,9 2,38E-07 22,9
BC048943 NM_001127685 1,48E-03 2,9 8,23E-05 3,4
Slc39a12 NM_001012305 6,97E-04 2,9 8,03E-08 123,3
Loxl4 NM_001164311 4,47E-04 2,8 7,52E-07 13,2
NAP114398-1 NAP114398-1 5,88E-04 2,8 2,70E-07 9,4
Slc1a1 NM_009199 6,31E-03 2,8 1,30E-07 27,2
Slc6a13 NM_144512 3,86E-03 2,8 9,05E-08 49,1
Car12 NM_178396 5,92E-03 2,8 2,86E-07 34,5
Iqgap2 NM_027711 3,55E-04 2,8 5,11E-08 13,4
Hist2h2aa1 NM_013549 2,53E-04 2,8 2,57E-07 5,7
Tgfa NM_031199 1,07E-03 2,8 2,66E-07 11,9
Spon1 NM_145584 3,68E-04 2,7 2,54E-07 7,4
Flot2 NM_008028 4,72E-03 2,7 1,50E-05 7,1
Tmem27 NM_020626 1,64E-03 2,7 3,15E-05 108,8
Trhde NM_146241 1,06E-03 2,7 7,15E-08 19,8
Hist2h4 NM_033596 8,85E-03 2,7 5,29E-05 7,0
Itgb8 NM_177290 2,57E-03 2,7 4,33E-07 14,9
Cbfa2t3 NM_001109873 6,18E-03 2,7 2,75E-06 11,8
Tcﬂ5 NM_178254 1,92E-03 2,7 4,74E-07 12,2
Adora2b NM_007413 3,61E-04 2,7 1,30E-07 37,0
Spock1 NM_009262 2,29E-03 2,7 1,28E-06 9,3
Gpam ENSMUST00000086868 8,06E-03 2,7 1,09E-03 3,0
Acsl6 NM_001033599 2,80E-03 2,7 2,96E-04 2,8
Lrp2 NM_001081088 6,73E-03 2,7 3,74E-06 10,7
Slc6a20a NM_139142 5,91E-04 2,6 3,38E-07 7,6
Nt5dc2 NM_027289 1,30E-03 2,6 9,65E-07 7,7
Krt18 NM_010664 2,04E-03 2,6 1,73E-06 7,2
(Continued)
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Finally, in order to facilitate comparative retinal studies between mouse and human, we
aimed to develop a list of interspecies RPE signature genes. We determined the overlap
between the mouse (64) and the human (171) RPE signature gene lists, resulting in an interspe-
cies RPE signature gene list of 22 genes (Table 2).
Gene expression profiles and functions of the mouse and human RPE
Using our previously published methodology [12–14], we analyzed the highest expressed genes
(highest 10th percentile:>90thP) of our mouse gene expression dataset (designated “Mouse
high RPE gene expression”) to determine the most important functionalities of the mouse
RPE. Subsequently, we compared the gene expression pathways and functional annotations
of the mouse and human RPE. The latter dataset was available from our previous studies
(“Human high RPE specific gene expression dataset” [12]. We used the Ingenuity Knowledge
Database to determine biological functions, canonical pathways and molecular networks spe-
cific for mouse and human RPE in vivo.
Functional annotation yielded statistically significant biological functions that were the
same for mouse and human (Table 3). We also found that many important canonical path-
ways for mouse and human RPE were similar. A summary of these findings is presented in
Fig 4.
In addition, we studied themolecular networks that were assigned to both the “Mouse”
and “Human” “high RPE gene expression” datasets. Functions annotated to these datasets on a
network level were more or less comparable (~75% overlap). The annotated functions included
developmental disorders, hereditary disorders, small molecule/drug metabolism and cellular
movement and maintenance. For an overview of the 10 most important networks for the
Table 1. (Continued)
CH<RPE>PR genes RPE compared to CH RPE compared to PR
GeneName SystematicName adj.P.Val FC RPE-CH adj P value FC RPE-PR
Slc16a8 NM_020516 1,87E-03 2,6 2,46E-07 14,9
Gabrb3 NM_008071 3,18E-04 2,6 4,83E-06 3,3
Mogat1 NM_026713 2,79E-03 2,6 5,42E-07 12,9
Hkdc1 NM_145419 2,81E-03 2,6 7,31E-06 5,9
Tmem56 NM_178936 4,12E-03 2,6 1,71E-08 148,2
Col4a4 NM_007735 2,96E-03 2,6 3,44E-06 4,0
Pebp4 NM_028560 4,39E-04 2,6 4,15E-08 13,5
Trpm3 NM_001035246 1,61E-04 2,6 5,35E-09 23,2
Hist1h4i NM_175656 1,08E-03 2,6 4,09E-06 4,7
A2m NM_175628 1,55E-03 2,5 8,00E-05 3,0
Bphl NM_026512 8,30E-04 2,5 2,48E-06 3,1
Slc7a10 NM_017394 1,64E-03 2,5 3,27E-08 33,6
Tshr NM_011648 4,22E-04 2,5 1,22E-08 58,3
Car14 NM_011797 3,58E-03 2,5 2,60E-07 18,4
Adra2c NM_007418 4,16E-03 2,5 4,30E-08 54,8
Fam13a NM_153574 5,08E-04 2,5 2,20E-08 19,6
Sgk3 NM_133220 3,38E-03 2,5 3,87E-06 7,0
Pde4b NM_019840 5,03E-04 2,5 8,98E-07 5,0
Slco1a4 NM_030687 3,07E-04 2,5 6,65E-09 32,7
doi:10.1371/journal.pone.0141597.t001
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“Mouse high RPE gene expression” dataset and the “Human high RPE gene expression” data-
set, and to see which networks overlap, see S3 Table and S4 Table. For illustrative purpose we
included an example of such a network (S3 Fig). For additional support of our findings in Inge-
nuity we also included a functional enrichment pathway analysis (KEGG analysis) in Webges-
talt [16]. This gives approximately the same results (S5 Table).
Genes highly expressed in mouse RPE but hardly in human RPE
To investigate the largest gene expression and functional differences between the mouse and
human RPE we subsequently compared the most extreme gene expression datasets of the two
species, namely the very high (highest 10th percentile,>90thP; high expression) and very low
(lowest 10th percentile<10thP; leaky expression) RPE expression datasets (GSE 66916).
Unexpectedly, the “Mouse high RPE gene expression” dataset (>90th P, 2663 genes) and the
“Human very low RPE gene expression”dataset (0-10th P, 1770 genes) had 101 genes in com-
mon (S6 Table). Functional annotation of these genes yielded 31 canonical pathways in Inge-
nuity, whose activity or metabolic route may be differentially affected in mouse and human
RPE. An overview is presented in Table 4.
Fig 3. Strategy to determine “Interspecies RPE signature genes”. Schematic overview of our comparison strategy: our “Mouse RPE signature genes”
dataset and “Human RPE signature genes” dataset, which contains (a modification of) two human RPE transcriptome datasets [12,15]. This resulted in a new
dataset, “Interspecies RPE signature genes”.
doi:10.1371/journal.pone.0141597.g003
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Table 2. The 22 signature genes that are specifically expressed in both RPE in mouse and in human.
Gene Symbol Genbank ID Mus Musculus Genbank Homo Sapiens
ADORA2B NM_007413 NM_000676
G-protein coupled adenosine receptor. This integral membrane protein stimulates adenylate cyclase activity in the presence of adenosine.
BMP4 NM_007554 NM_001202
A member of the bone morphogenic protein family which is part of the transforming growth factor-beta superfamily. The superfamily includes large families
of growth and differentiation factors.
CA14 NM_011797 NM_012113
Carbonic anhydrases are a large family of zinc metalloenzymes that catalyze the reversible hydratyion of carbon dioxide.
CSPG5 NM_001166273 NM_001206942.1
A proteoglycan that may function as a neural growth and differentiation factor.
CTSD NM_009983 NM_001909.4
An aspartic protease resident in endosomal and lysosomal compartments of all eukaryotic cells.
GPAM ENSMUST00000086868
A mitochondrial enzyme which prefers saturated fatty acids as its substrate for the synthesis of glycerolipids.
ITGB8 NM_177290 NM_002214.2
Cell surface adhesion receptor mediating cell-adhesion to extra cellular matrix or to other cells, through hetero dimerization and connecting to the
cytoskeleton and various signaling molecules within cells.
KRT18 NM_010664 NM_000224
Keratin 18 is a type I cytokeratin (this type constitutes the type I intermediate ﬁlaments of the intracytoplasmatic cytoskeleton, which is present in all
mammalian epithelial cells), together with Krt8 is the most common found product of the intermediate ﬁlament gene family. They are expressed in single
layer epithelial tissues of the body.
RDH10 NM_133832 [NM_172037
A retinol dehydrogenase, which converts all-trans-retinol to all-trans-retinal, with preference for NADP as a cofactor.
RGR ENSMUST00000022338 NM_002921
A putative retinal G-protein coupled receptor and acts as a photoisomerase to catalyze the conversion of all-trans-retinal to 11-cis-retinal.
RLBP1 NM_020599 NM_000326
Retinaldehyde binding protein 1. carries 11-cis-retinaldehyde or 11-cis-retinal as physiological ligands. It may be a functional component of the visual
cycle.
SEMA3C NM_013657 NM_006379.3
Binds to plexin family members and plays an important role in the regulation of developmental processes.
SLC16A8 [MCT3] NM_020516 NM_013356
Belongs to a family of monocarboxylate transporters. It is expressed in the basolateral membrane of the RPE.
SLC39A12 NM_001012305 NM_152725
Zinc transporter, which is a cofactor for hundreds of enzymes and therefore normal cell function.
SLC6A13 NM_144512 NM_016615
Encodes a sodium- and chloride-dependent GABA transporter [GAT2]
SLC6A20 NM_139142 NM_020208
Encodes an amino acid transmembrane transporter that mediates the transport of small hydrophilic substances across cell membranes.
SLC7A10 NM_017394 NM_019849
Encodes an amino acid transmembrane transporter that mediates high-afﬁnity transport of D-serine and several other neutral amino acids.
SPOCK1 NM_009262 NM_004598
Encodes he protein core of a seminal plasma proteoglycan containing chondroitin- and heparin-sulfate chains.
SULF1 NM_172294 NM_015170
Enzyme which can modulate the activity if heparan sulfate, thereby inﬂuencing the regulation of cell growth, proliferation, differentiation and migration.
TMEM27 NM_020626 NM_020665
binds to amino acid transporters and regulates their expression on the plasma membrane
TMEM56 NM_178936 NM_152487
function unknown
TRPM3 NM_001035246 NM_206948
(Continued)
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The core analysis of the 101 differentially expressed genes resulted in 7molecular networks.
The associated representative functions include developmental disorders, connective tissue
disorders, ophthalmic disease, neurological disease, drug metabolism and cancer. These net-
works are presented in S7 Table. For illustrative purpose we included an example of one of
these networks, see S4 Fig. For additional support of our findings in Ingenuity we also included
a functional enrichment pathway analysis (KEGG analysis) in Webgestalt. This gives approxi-
mately the same results (S8 Table).
Genes highly expressed in human RPE but hardly in mouse RPE
In order to identify additional differences between mouse and human RPE, we also compared
the “Human high RPE gene expression” dataset (>90th P, 2399 genes) and the “Mouse very
low RPE gene expression”dataset (10th P, 3374 genes). This analysis yielded 54 genes (S9
Table). We also functionally annotated this set of genes using the Ingenuity knowledge data-
base. The significant canonical pathways assigned to this dataset included PXR/RXR activa-
tion, nicotine degradation and bupropion degradation. Ingenuity analysis yielded four
networks. The functional annotations of these networks include drug metabolism, nucleic acid
Table 2. (Continued)
Gene Symbol Genbank ID Mus Musculus Genbank Homo Sapiens
Belongs to the family of transient receptor potential channels. TRP channels are cation-selective channels important for cellular calcium signaling and
homeostasis.
Derived from a comparison between our “Mouse RPE signature genes” dataset (this study) and two (modiﬁed) studies on the human RPE transcriptome
[12,15]. We show the gene symbol, genbank ID for both species and the GO annotation of each gene.
doi:10.1371/journal.pone.0141597.t002
Table 3. Overview of the major biological functions found in a functional annotation by Ingenuity of the “Mouse High RPE gene expression” and
“Human High RPE gene expression” datasets.
Mouse High RPE expression Human High RPE expression
Disease and Disorders p-value Disease and Disorders p-value
Neurological Disease 7,31E-51-9,20E-05 Neurological Disease 7,54E-57-2,18E-05
Psychological Disorders 8,09E-44-9,20E-05 Psychological Disorders 2,04E-49-2,26E-07
Skeletal and Muscular Disorders 2,84E-41-2,62E-05 Skeletal and Muscular Disorders 5,84E-47-2,18E-05
Infectious Disease 5,89E-36-9,33E-05 Hereditary Disorder 1,77E-39-2,18E-05
Hereditary Disorder 6,10E-34-4,77E-05 Infectious Disease 2,29E-32-1,08E-05
Molecular and Cellular Functions Molecular and Cellular Functions
Cellular Growth and Proliferation 7,20E-39-8,57E-05 Cell Death and Survival 3,55E-42-2,06E-05
Cell Death and Survival 3,43E-38-5,57E-05 Cellular Growth and Proliferation 6,25E-37-1,64E-05
Cell Morphology 5,70E-25-9,33E-05 Protein Synthesis 1,77E-22-2,14E-05
Protein Synthesis 5,77E-22-9,28E-06 Cell Morphology 9,15E-21-1,66E-05
Cellular Development 3,25E-17-8,57E-05 Gene Expression 2,01E-20-2,15E-05
Physiological System Development & Function Physiological System Development & Function
Organismal Survival 7,97E-23-7,93E-06 Organismal Survival 3,18E-23-3,18E-23
Embryonic Development 9,01E-18-8,15E-05 Organismal Development 2,63E-16-2,01E-05
Organ Development 9,01E-18-8,15E-05 Nervous System Development and Function 3,17E-16-1,66E-05
Organ Morphology 9,01E-18-9,33E-05 Embryonic Development 2,01E-14-1,65E-05
Organismal Development 9,01E-18-8,15E-05 Organ Development 3,73E-13-1,45E-05
The p-value for these categories are indicated as a range because each category contains sub-functions that have their own p-value.
doi:10.1371/journal.pone.0141597.t003
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metabolism, small molecule biochemistry, cardiovascular disease and humoral immune
response. The molecular pathways are presented in S10 Table. We also included an illustrative
example of such a network, see S5 Fig.
Among the major biological functions and disease that came out of this analysis were
hereditary hearing loss and Usher syndrome. Major differences inmolecular cellular func-
tions identified by Ingenuity were drug metabolism, nucleic acid metabolism, small molecule
biochemistry and lipid metabolism. For additional support of our findings in Ingenuity we
included a functional enrichment pathway analysis (KEGG analysis) in Webgestalt. This gives
approximately the same results (see S11 Table).
Discussion
In this study, we aimed to find similarities and differences between mouse and human RPE
using RPE specific gene expression profiles and functional annotation on the same experimen-
tal platform. Our current data may be important for translational studies in age related macular
degeneration, for creating and use of a representative AMDmouse model. Thus, we discuss
here those aspects of our analyses of human and mouse RPE that are relevant for AMD.
Similarities and differences between mouse and human RPE
transcriptomes in relation to AMD
Apart from the obvious similarities, there are a number of well-known differences between
human and mouse RPE and adjacent tissues. These include the absence of a macula in the
mouse, the difference in rod and cone number and distribution, and a thinner Bruch’s mem-
brane in the mouse. Mouse models are available for wet and dry AMD, mimicking several of
the pathological features seen in AMD, but no model recreates all of the AMD characteristics
[17–20].
We were interested in the potential usefulness of our entire comparative human and mouse
gene expression dataset for the investigation of AMD (mouse models). Interestingly we did
find similarities and differences in relation to a number of previously published (patho-) bio-
logical aspects related to AMD, namely oxidative stress, zinc homeostasis, presence of proteins
of the complement system that are found in drusen, proteins in Bruch´s membrane,
Fig 4. Most significant canonical pathways identified by Ingenuity for the “Mouse High RPE gene expression” and “Human High RPE expression
gene expression” datasets. The left y-axis displays the–log of Benjamini-Hochberg corrected p-value. The right y-axis displays the ratio of the number of
genes derived from our dataset, divided by the total number of genes in the pathway. The blue line indicates the threshold of the BH corrected p-value of 0.1.
doi:10.1371/journal.pone.0141597.g004
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involvement in neovascularization and tight junctions. These differences and similarities are
important to develop and use representative mouse models for AMD, and they may be partly
responsible for (the observed) discrepancies between mouse model and human patients.
Age related macular degeneration: Oxidative Stress. The RPE suffers from chronic oxi-
dative stress due to the exposure to light, relatively low oxygen levels, and daily phagocytosis
and digestion of photoreceptor outer segments [21]. The mainstream hypothesis in AMD is
that prolonged oxidative stress harms the vitality of the RPE and oxidatively modified drusen-
Table 4. Overview of significant canonical pathways assigned by the Ingenuity knowledge database
to the 101 genes that are the result of comparing the “Mouse high RPE gene expression” and the
“Human very low RPE gene expression” datasets.
Endocrine Signaling & Metabolic Function
Ephrin Receptor Signaling
PEDF Signaling
Protein Kinase A Signaling
Gαq Signaling
FGF Signaling
Phospholipase C Signaling
NGF Signaling
GNRH Signaling
PXR/RXR Activation
Ephrin B Signaling
Immunological Function
iCOS-iCOSL Signaling in T Helper Cells
Role of NFAT in Regulation of the Immune Response
Dendritic Cell Maturation
B Cell Receptor Signaling
IL-8 Signaling
Thrombin Signaling
PKCθ Signaling in T Lymphocytes
CD28 Signaling in T Helper Cells
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis
GM-CSF Signaling
PI3K Signaling in B Lymphocytes
Basic pathways of cellular (dys)function
Prostate Cancer Signaling
Regulation of the Epithelial-Mesenchymal Transition Pathway
Wnt/Ca+ pathway
P2Y Purigenic Receptor Signaling Pathway
Estrogen-Dependent Breast Cancer Signaling
Colorectal Cancer Metastasis Signaling
Epithelial junctions
Tight Junction Signaling
Epithelial Adherens Junction Signaling
Vesicle mediated transport
Clathrin-mediated Endocytosis Signaling
Oxidative stress
Hypoxia Signaling in the Cardiovascular System
doi:10.1371/journal.pone.0141597.t004
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bound fatty acids and proteins. These are subsequently recognized by the body as non-self, and
invoke a chronic, complement mediated, immune response [22,23].
Oxidative stress in the RPE is, among others, mediated by the manganese superoxidase dis-
mutase protein family, consisting of SOD1, SOD2 and SOD3; Respectively, these SODs exert
their antioxidant effect in the cytosol, mitochondria and extracellular matrix [24,25]. We
found similar expression of SOD1 (very high) and SOD3 (moderate) in human and mouse
RPE. In contrast, we found that the SOD2 gene was highly expressed in the mouse RPE but
only at low levels in the human RPE (Table 5). Reactive Oxygen species (ROS)-associated mito-
chondrial DNA damage was previously correlated with the progression of AMD [26–28]. But
association studies between genetic variants in the SOD2 gene and AMD pathogenesis yielded
conflicting results [27,29].
For both SOD1 and SOD2 mouse models were developed. Sod1-/-mice and Sod2-/-mice
both show a thickened Bruch’s membrane, photoreceptor atrophy and reduced electroretino-
graphic response [30]. Sod2-/-mice lacked drusen like deposits but have RPE atrophy [31,32].
In the Sod1-/-mice, 10% of the older animals showed choroidal neovascularization and 86%
showed drusen-like deposits that contained several markers of drusen [33].
The previous studies on SOD family members and the different expression we find between
mouse and human, indicate that all three SOD family members may be critically involved in
the local defense against oxidative stress, although the mitochondrial SOD2 may play a more
important role in the mouse RPE than in the human RPE.
In addition to SODs, zinc has also been implicated in mediating oxidative stress. The retina
and especially drusen contain high amounts of zinc [34]. There is an age related decrease in
systemic and cellular zinc levels in human RPE cells, that correlates with several age related
pathologies like AMD [35]. In 1988 the first clinical trial favoring zinc supplementation in
AMD was published [36]. Since that time, multiple studies suggested that zinc reduces the oxi-
dative burden on the retina although the underlying molecular mechanism(s) is unknown
[7,37–39]. Zinc ions reach the retina by specific transporters. We determined which zinc trans-
porters are highly expressed in mouse and human RPE. In the highest 10th percentile of the
Table 5. SOD1, SOD2, SOD3 gene expression in human andmouse RPE.
Mouse Human
isoenzyme Reporter Percentile Reporter Percentile
SOD1 NM_011434 High NM_000454 High
SOD2 NM_013671 High NM_000636, BM994509, AL050388 Low
SOD3 NM_011435 Intermediate NM_003102 Intermediate
Sod1 and Sod3 are highly and moderately expressed respectively, in both species. Sod2 gene expression has a low expression in human RPE. In
contrast it has a high expression in mouse RPE.
doi:10.1371/journal.pone.0141597.t005
Table 6. Overview of zinc transporters that are highly expressed in human andmouse RPE.
Mouse Human
Zinc transporter reporter Zinc transporter reporter
Slc39a1 NM_013901 SLC39A8 NM_022154
Slc39a4 NM_028064 SLC39A12 NM_152725
Slc39a7 NM_008202 SLC39A13 NM_152264
Slc39a12 NM_001012305
doi:10.1371/journal.pone.0141597.t006
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mouse RPE transcriptome we found expression of Slc39a1, Slc39a4, Slc39a7 and Slc39a12. In
the highest 10th percentile of the human RPE transcriptome we observed expression of
SLC39A8, SLC39A12 and SLC39A13 (Table 6). Our data are largely in agreement with those of
Leung and coworkers [40], who determined the expression of a large number of zinc transport-
ers in cultured human RPE cells.
Interestingly, we found that Slc39a4 was highly expressed in mouse RPE, but not in the
human RPE. Indeed, Dufner-Beattie et al demonstrated the importance of this transporter in a
Slc39a4 knockout mouse, which develops severe abnormalities of the nervous system, such as
anophthalmia, exencephaly and hydrocephalus [41]. Our finding (in older human donor eyes)
may be explained by an age-related effect, since Leung et al [40] found that Slc39a2 and Slc39a4
expression and corresponding zinc uptake are reduced in RPE from older individuals. We
determined the Slc39a4 expression in RPE of five-month-old mice.
Age-related macular degeneration: drusen and complement system. Chronic inflamma-
tory and immune mediated events at the level of the Bruch’s membrane and drusen play critical
roles in AMD pathogenesis [42]. Initially, complement system related factors were immune-
localized to drusen, a hallmark of AMD. Subsequently, genetic studies showed an association
between polymorphisms of several complement pathway genes, such as CFH, CFB, C3, CFHRs,
and AMD [2]. In our dataset we found high expression of several complement factors in the
human and mouse RPE (Fig 5), which may be of interest for studies of the complement system
and AMD pathogenesis in a mouse model.
Interestingly, C1QTNF5 is highly expressed in the both mouse and human RPE. Mutations
in C1QTNF5 have been associated with late-onset retinal degeneration. A C1qtnf5 S163R
knock-in mouse model developed by Chavali et al showed many pathological features of AMD,
such as RPE abnormalities, photoreceptor loss, retinal vascular leakage [43]. Contrary to this,
Shu et al. developed a C1qtnf5 Ser163Arg knock-in mouse model that lacked any phenotypic
abnormality [44]. The reason for this discrepancy is currently not clear.
We observed that the complement factor H related 1 gene (CFHR1) is highly expressed in
human RPE, but not in mouse RPE. Our data corroborate, in part, the data of Luo et al (2011)
who found absence of Cfhr1 expression in mouse retina, RPE and choroid [45]. The regulation
of the complement system (in AMD) is extremely complex, multiple regulators and feedback
loops exist and the detailed mechanisms underlying the complement regulation at the RPE
Fig 5. Overview of highly expressed complement factors in the human andmouse RPE. Complement factors in the overlay of the circles are highly
expressed in RPE of both species.
doi:10.1371/journal.pone.0141597.g005
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interface and macular area is not known. Nonetheless, several studies suggested that CFHR1,
together with CFHR3, plays a central role in complement regulation of AMD. Several studies
suggest that the absence of CFHR1 and/or its family member CFHR3 are highly protective
against AMD in humans [46–48].
Age-related macular degeneration: Bruch’s membrane and neovascularization. Our
data reveal differences in mouse and human RPE gene expression related to two other essential
aspects of age-related macular degeneration: The build-up and turnover of Bruch’s membrane
and neovascularization. Bruch’s membrane is a sheet of extracellular matrix that lies in between
the RPE and the choroid. The extracellular matrix components that form the BM are made by
RPE and CH. The BM has a major clinical significance because of its critical role in the patho-
genesis of AMD [2].
We found that Timp2 and Col3a, genes involved in extracellular matrix formation or turn-
over, are highly expressed in the mouse RPE, but not in human RPE. Vice versa, COL16A1 is
highly expressed in the human RPE, but not in mouse RPE.
We also found large inter-specifics gene expression differences annotated with the term
“Angiogenesis”. “Angiogenesis” refers to the process whereby new blood vessels are formed. In
the context of our RPE/AMD analysis, choroidal blood vessels usually penetrate the BM and
from new (leaky) vessels underneath the RPE. Our data specifically suggest expression and
functional differences for the angiogenic factors Fgf23 and Fgfr1 (highly expressed in mouse
RPE), as well as the prostaglandin synthase PTGES andHS6ST1 (highly expressed in human
RPE). In summary, our results suggest specific differences between mouse and man in terms of
BM buildup or turnover, as well as related to neovascularization.
Age-related macular degeneration: tight junctions of the outer blood-retina barrier.
The RPE constitutes the outer blood-retina barrier (oBRB). The tight junctions between neigh-
boring RPE cells bind the monolayer and separates the outer layer of the neural retina from the
choriocapillaris [49]. The RPE maintains the integrity of the oBRB through the tight junctions,
which is important for control of fluid leakage, solute transport and immune reactions. oBRB
supports the functional homeostasis of the retina. Disruptions of RPE cell junction and barrier
integrity are associated with AMD [50,51]. We compared the tight junction gene expression of
mouse and human RPE by investigating the distribution of these genes in four categories: high
expression (>90th percentile), moderate (50-90th percentile), low (10-50th percentile) and very
low (<10th percentile) (Fig 6).
Overall, we find limited overlap of tight junction gene expression between mouse and
human RPE. Our data suggest that the composition of the outer blood retina barrier differs
between mouse and human. More investigation is necessary to determine the possible physio-
logical or pathobiological effect of these differences.
Conclusion
In summary, in this study we determined 64 signature genes for mouse RPE, 171 signature
genes for human RPE. We also deduced 22 mouse-human interspecies signature genes. We
next analyzed the general mouse and human RPE gene expression profiles, and we found that
(patho-) biological functions and canonical pathways assigned to the RPE of both species were
highly similar. Nonetheless, more detailed studies, including analysis of specific molecular net-
works as well as extreme gene expression differences between mouse and human (expression
of 155 genes), suggests substantial biological differences.
These similarities and differences may be important for the development of new therapeutic
strategies and translational studies in age-related macular degeneration.
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Methods
Strengths and limitations of the study design
The technical and methodological strengths and limitations of this approach have been exten-
sively discussed elsewhere [12,13]. Our lab has more than 10 years’ experience in cellular micro-
array studies. In short, the strengths of this study include the use of selected healthy and freshly
frozen samples with short post-mortem times. Sample preparation is characterized by minimal
technical handling (such as mechanical or enzymatic dissociation, scraping, heating etc). In this
way, the native “in vivo” gene expression profile is preserved. Next, we use laser dissection
microscopy (LDM) of cryosections of the relevant cell-type. The use of the LDM ensures highly
specific and homogeneous cell-type collection. After RNA isolation, we check RNA integrity and
the quantity using the Agilent Bio-analyzer and Nanodrop during the procedure multiple times.
Samples are labeled with Cy3 and Cy5 from the 3’-prime end to minimize effects from possible
RNA degradation. RNA/samples that do not meet our quality criteria at any point in the proce-
dure are discarded of. We use a common reference design, which also serves as an internal tech-
nical control, and a large-scale 44k microarray.
There are also a number of limitations of our studies. Given the lengthy procedure of sample
selection, procedure and extensive quality controls, we usually include a limited number of
“the very best samples” in our final microarray analysis. The consequence is that we only can
detect consistent similarities and differences (and not all, strongly variable or transient ones) in
gene expression between samples.
Another limitation is that some degree of cellular contamination of adjacent cell layers in
samples is unavoidable, even when we use meticulous laser dissection microscopy in the nicely
structurally stacked retina. To overcome this problem we included the gene expression of the
adjacent layers in our analysis: the so-called “double selection procedure” (Fig 2) [12].
Fig 6. This diagram depicts the tight junction gene expression of mouse and human RPE, divided in four categories: high expression (>90th
percentile), moderate (50-90th percentile), low (10-50th percentile) and very low (<10th percentile).On the x-axis the four categories are displayed and
on the y-axis the amount of genes found in a category is depicted. Light blue circles contain genes expressed in mouse RPE, Dark blue circles genes
expressed in human RPE. Genes inside the overlapping parts of the circles are expressed in the RPE in both species in that category.
doi:10.1371/journal.pone.0141597.g006
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There are two limitations which are specific to this mouse-human study: The first is that
there may be an oligo design difference for the comparative orthologous human and mouse
genes on the Agilent whole Mouse and whole Human microarray. While, frequently, multiple
different oligo’s for a single gene and reference genes may be present on the micro-array, this
may hamper direct comparison between mouse and human gene expression data. To overcome
this problem, we ranked the gene expression data of each sample/species according to percen-
tiles, and divided it into four expression groups: high, moderate, low and very low expression
[13,52]. By comparing the most extreme datasets, the high expressed genes with the very low
expressed genes, between the two species; we could identify physiological relevant differences
between the mouse and human RPE gene expressions, since these major differences could not
be caused by different affinities alone. For further confirmation, we identified the genes that we
described in our paper also by sqRT-PCR.
Finally, the mouse and human tissue used in this study had different post-mortem times: The
mouse eyes were enucleated and embedded immediately after death, while for the donor eyes the
post-mortem delay was between 16 and 22 hours. On the other hand, it has been shown that this
has minimal effect on the RNA integrity of brain tissue. Up to 30 hours postmortem delay did not
affect the mRNA [53]. During our experiments, we thoroughly checked the RNA integrity using
BioAnalyzer, multiple times. In addition, since we designed labeling primers on the 3 prime end of
the genes, potential starting degradation (first occurring at the 5 prime end) did not affect our gene
expression results. A full description of the methodological (dis) advantages is beyond the scope of
this paper. However, our approach enables us to determine highly specific RPE gene expression
with a very limited amount of contamination, which is also corrected for in the analysis.
Mouse eyes, tissue processing and cell sampling
The study on mouse material was carried out in strict accordance with the recommendation in
the Guide for the Care and Use of Laboratory Animals under the Dutch law, which is in accor-
dance with the international declaration of Helsinki. The protocol was approved by the Com-
mittee on Ethical of Animal Experiments of the Netherlands Institute for Neuroscience (NIN),
Royal Dutch Academy for Science (KNAW), the Netherlands (DEC protocol NIN 09.45).
Mouse choroid, RPE and photoreceptors were obtained from eyes of healthy 5 months (-/+2
weeks) old C57BL/6 mice (J strain). We confirmed by sqRT-PCR that the mice of this sub
strain (C57BL/6JOlaHsd) did not carry the rd8 mutation in the Crb1 gene that has been found
in C57BL/6N strains [54]. For each tissue we used 3 mouse eyes (and 3–6 selected human
donor eyes). Mice were raised in a room with a temperature around 21°C, on a 12:12-h light-
dark cycle, and fed with standard pellet laboratory chow and water ad libitum. By the age of 5
months (-/+2 weeks) they were anesthetized with CO2/O2 and killed by cervical dislocation.
The eyes were enucleated, embedded in OCT and snap frozen in liquid nitrogen. Until further
use the eyes were stored in an -80°C freezer. We selectively cut out the CH, RPE and PR with a
laser dissection microscope (PALM Carl Zeiss, MicroImaging GmbH, Munich, Germany). For
this the eyes were cut in 20uM cryosections for the photoreceptors and 12uM for the RPE and
the choroid. For every sample one whole eye was used. We used Cresyl Violet staining to iden-
tify photoreceptor cells. Before the dissection of the choroid the RPE was removed to prevent
as much contamination as possible. After processing the tissue and running the microarray, we
determined the (low) variability of the samples using a multidimensional scaling plot (S6 Fig).
RNA isolation and amplification
RNA isolation, amplification and labelling procedures were carried out essentially as described
elsewhere [14]. Quality of tRNA was checked with a Bioanalyzer assay (RNA 6000 Pico Kit,
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Agilent Technologies, Amstelveen, The Netherlands). RNA integrity numbers of tRNA of
mouse CH ranged from 4.9 to 6.9, of the mouse RPE ranged from 4.9 to 7.2 and of mouse PR
ranged from 5.5 to 7.6. In our microarray study we used a common reference design. The com-
mon reference was prepared from mouse RPE/choroid that was isolated, amplified using the
same methodology as our experimental samples, and labelled with Cy3 (Cy3 mono-reactive
dye pack, GE Healthcare UK, Little Chalfont, Buckinghamshire, UK).
See Janssen et al. [14] for a more detailed description of the laser dissection procedures,
RNA processing and microarray procedures.
Microarray data analysis
The microarray files were analysed and processed using Agilent Feature Extraction Software
(Agilent Technologies, version 9.5.3.1). We included examples of our strict quality control
assessment of the hybridizations in the supplementary file S7 Fig and S8 Fig. Data were
imported into R (version 2.14.0 for Windows, R Development Core Team, 2009) using
LIMMA in the Bioconductor package. We studied the differences between the RPE and the
photoreceptors making a statistical comparison using LIMMA for determining significantly
changed genes (R package LIMMA, including Bayesian statistics). We did the same for RPE
and the choroid:
Using a common reference design, in LIMMA we first estimated the difference between the
sample (either CH / RPE / PR) and the common reference (hybridized against each other on a
two channel array). Next, the differences between both RPE and CH or between RPE and PR
were estimated. Subsequently, LIMMA fitted a linear model to the expression data for each
gene. LIMMA uses empirical Bayes statistics to moderate the standard error of the estimated
log-fold changes which results in more stable inference and improved power [55]. A fully
detailed description of the script that was used in LIMMA is available upon request.
We selected the genes that had a positive fold change, meaning that they are higher
expressed in the RPE than in either the photoreceptors or the choroid, of more than 2.5. Cut-
off value for statistical significant difference was an adjusted p-value of less than 0.01 after Ben-
jamini-Hochberg correction for multiple testing. Two data subsets were created that either
contained all genes that show a significant higher expression in the RPE compared to the pho-
toreceptors (RPE>PR), or a significant higher expression in the RPE compared to the choroid
(RPE>CH). The volcano plots that visualize the symmetrical spread of the differentially
expressed genes are included in S9 Fig. Next we compared these two subsets to determine the
genes that are present in both lists using a comparison analysis in IPA (Ingenuity Systems).
These represent RPE specifically expressed genes. To visualize these significant differences in
gene expression levels we included a figure depicting the mean and (low) standard deviations
(S10 Fig) and we included a figure of the mean and (the low) standard deviations of the genes
mentioned in the discussions section (S11 Fig).
Data analysis of two microarray studies on the human RPE
transcriptome
To detect possible contamination of the choroid and the photoreceptors in the list of Strunni-
kova et al we used the expression data of the human choroid and the human photoreceptors as
determined within our group [12]. We assumed that the main source of contamination of RPE
sample(s) using this methodology comes primarily from the set of highest expressed genes in
either the PR or CH. Consequently, we determined the highest 10th percentile of the average
gene expression for both the photoreceptors and the choroid in Microsoft Excel. We ran a
comparison analysis in IPA (Ingenuity Systems) to subtract the genes in the highest 10th
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percentile of photoreceptors and choroid from the 154 genes determined as RPE specific by
Strunnikova et al [15]. We merged the two human RPE specific gene expression lists in Ingenu-
ity using a comparison analysis.
Interspecies RPE signature genes
We compared the human RPE signature gene expression list, that we determined using the
Booij et al list and the corrected Strunnikova et al list (Fig 3), with our new mouse RPE signa-
ture gene expression. We ran a comparison analysis in Ingenuity, which uses the Entrez Gene
identifier, to investigate which genes are found in both datasets and thus are interspecies
specific.
Confirmation of gene expression data by sqRT-PCR
We confirmed our microarray data with sqRT-PCR. For a detailed description of the
sqRT-PCR, see Janssen et al. 2013 [13]. In short, sqRT-PCR was carried out using intron-span-
ning primers on cDNA from laser dissection microscopy derived samples, using three biologi-
cal replicates. To minimize effects of RNA degradation artefacts, we generated primers near the
3’end of the gene. We quantified the gene expression in ImageJ and normalized expression by
comparing it to the measured expression of housekeeping gene Bact.
Previously, we confirmed the human gene microarrays [12]. In the current study study, we
selected a total of 27 genes to confirm our mouse microarray data. First, we selected randomly
11 highly expressed genes from our “Mouse RPE signature genes” dataset (Bmp4, Rlbp1, Rgr,
Krt18, Sgk3,Man1a, F3, Sulf1, Thsr, Col4a4, SLc16a8). For 9 out of the 11 “Mouse RPE signa-
ture genes” we found the highest expression levels in the mouse RPE and the lowest in the CH
and PR (Fig 1). Only Thsr and Slc16a8 showed highest expression in CH.
We next selected 8 well-established RPE specifically expressed genes (Mertk, Rrh, Tyr,
Rpe65, Rdh5, Lrat, Tjp1 and Trpm3). For 7 out of 8 of the well-established RPE specific genes,
we found highest expression in the mouse RPE and lower in the CH and PR (S1 Fig). Only Tyr
showed highest expression in CH in our RT-PCR.
We also included sqRT-PCR for genes that were mentioned in the Discussion section to fur-
ther technically validate our microarray. We selected 8 genes, 6 genes that are highly expressed
(found in the highest 10th percentile of the mouse RPE microarray; Sod1, Sod2, Slc39a4, Timp2,
Col3a, Cldn1) and 2 genes that are low expressed (found in the lowest 10th percentile of the
mouse RPE microarray; Cldn8,Hs6st1). We compared the expression levels of these genes with
the expression level of Bact. For all genes we found the expected confirmatory result (S2 Fig).
Overall, in this study, we confirmed the expression levels for 24 out of 27 genes (89%), which is
in line with the cumulative RT-PCR confirmation rate (87%) of all previous microarray studies
(using similar tissue and methodology).
Supporting Information
S1 Fig. Confirmation of well-established RPE genes by sqRT-PCR. Bact was used to normal-
ize gene expression in mouse CH, RPE and PR. The light blue bars indicate the CH, the blue
bars indicate RPE and the dark blue bars indicate PR. Similar to the microarray data the
expression level is highest in the RPE and lowest in the PR.
(TIF)
S2 Fig. Confirmation of microarray results mentioned in the discussion by sqRT-PCR.
Dark blue bar indicate Bact expression level, the blue bars show the expression level of genes
that were highly expressed on the microarray en light blue bars indicate expression of genes
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that showed very low expression on the microarray.
(TIF)
S3 Fig. Example of a molecular network generated by Ingenuity Pathway Analysis from the
“Mouse high RPE gene expression” dataset.
(TIF)
S4 Fig. Example of a molecular network assigned by Ingenuity to the 101 genes that are the
result of comparing “Mouse high RPE gene expression” and the “Human low RPE gene
expression” dataset.
(TIF)
S5 Fig. Example of a molecular network assigned by Ingenuity to the 54 genes that are the
result of comparing “Human high RPE gene expression” and the “Mouse low RPE gene
expression” dataset.
(TIF)
S6 Fig. Cluster analysis using multidimensional scaling plot.We analyzed the normalized
expression intensities of the nine samples that were used in this study, with a multidimensional
scaling plot. It shows that the samples within a group are highly similar.
(TIF)
S7 Fig. Feature extraction quality control, background correction. Plot of the log of the red
background-corrected signal versus the log of the green background-corrected signal for non-
control inlier features for all nine samples after hybridization. The linearity of the plots indicate
the appropriateness of background method choices.
(TIF)
S8 Fig. Feature extraction quality control, spatial distribution. The spatial distribution of
up- and down-regulated features is evenly spread throughout the array for all nine samples.
(TIF)
S9 Fig. Volcano plots of differential expression RPE-CH and RPE-PR. Shown is the spread
of the differentially expressed genes derived from the t-tests. The positive (higher expression in
RPE) and negative (higher expression in the CH or in the PR) fold changes are approximately
symmetrically divided.
(TIF)
S10 Fig. Expression intensities of the mouse RPE signature genes. Shown are the means and
standard deviations in the mouse CH, RPE and PR.
(TIF)
S11 Fig. Expression intensities of the genes mentioned in the discussions section. Shown
are the means and the standard deviation in the mouse RPE. The upper line indicates the cut-
off value for the highest 10th percentile, the middle line the cut-off value for the 50th percentile
and the lowest line the cut-off value for the lowest 10th percentile.
(TIF)
S1 Table. Genes expressed high in CH vs RPE and PR vs RPE.
(XLSX)
S2 Table. 171 genes Human RPE signature genes.
(XLS)
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S3 Table. Molecular networks of the Mouse high RPE gene expression dataset.
(XLS)
S4 Table. Molecular networks of the Human high RPE gene expression dataset.
(XLS)
S5 Table. Molecular networks of the Mouse and Human high RPE gene expression dataset
in Webgestalt.
(XLSX)
S6 Table. 101 genes highly expressed in mouse RPE but hardly in human RPE.
(XLS)
S7 Table. Molecular networks of the 101 genes highly expressed in mouse RPE but hardly
in human RPE.
(XLS)
S8 Table. Molecular networks of the 101 genes highly expressed in mouse RPE but hardly
in human RPE in Webgestalt.
(XLSX)
S9 Table. 54 genes highly expressed in human RPE but hardly in mouse RPE.
(XLS)
S10 Table. Molecular networks of the 54 genes highly expressed in human RPE but hardly
in mouse RPE.
(XLS)
S11 Table. Molecular networks of the 54 genes highly expressed in human RPE but hardly
in mouse RPE in Webgestalt.
(XLSX)
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